People · Operator
Named in public records as an officer, director or promoter · active 2013–2021 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Vaxess Technologies, Inc. | — | Biotechnology | Series C | $138.2M | $270.2M | 2021 |
| Immunome Inc. | — | Biotechnology | Series B | $71.0M | $752.8M | 2019 |
| Taris Biomedical Inc | — | Biotechnology | Series B | $36.9M | $535.8M | 2013 |
Purnanand Sarma at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Purnanand Sarma on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Langer | 1 | 36 |
| Michael Greeley | 1 | 15 |
| Kevin Bitterman | 1 | 15 |
| Ann DeWitt | 1 | 10 |
| Peter Kolchinsky | 1 | 8 |
| Aaron Sandoski | 1 | 7 |
| Robert Crane | 1 | 7 |
| Diane Marcou | 1 | 5 |
| Michael Cima | 1 | 4 |
| Rachel Sha | 1 | 4 |
| Cary Pfeffer | 1 | 4 |
| Christine Bunt | 1 | 4 |
| Dennis Ausiello | 1 | 4 |
| I Wistar Morris | 1 | 3 |
| Fenel Eloi | 1 | 3 |
| Ed Kania | 1 | 3 |
| Michael Schrader | 1 | 3 |
| Mario Barro | 1 | 3 |
| James Connolly | 1 | 3 |
| Mark Tracy | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.